Improving Antipsychotic Adherence Among Patients with Schizophrenia
Marcia T. Valenstein MD AB
VA Ann Arbor Healthcare System
Ann Arbor, MI
Funding Period: July 2002 - June 2006

BACKGROUND/RATIONALE:


OBJECTIVE(S):


METHODS:


FINDINGS/RESULTS:
Not yet available.

IMPACT:
Not yet available.

PUBLICATIONS:

Journal Articles

1. Sajatovic M, Blow FC, Kales HC, Valenstein M, Ganoczy D, Ignacio RV. Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder. International Journal of Geriatric Psychiatry. 2007; 22(10): 992-8.
2. Sajatovic M, Valenstein M, Blow F, Ganoczy D, Ignacio R. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatric Services. 2007; 58(6): 855-63.
3. Kreyenbuhl JA, Valenstein M, McCarthy JF, Ganoczy D, Blow FC. Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns. Psychiatric Services. 2007; 58(4): 489-95.
4. Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disorders. 2006; 8(3): 232-41.
5. Kreyenbuhl J, Valenstein M, McCarthy JF, Ganoczy D, Blow FC. Long-term combination antipsychotic treatment in VA patients with schizophrenia. Schizophrenia Research. 2006; 84(1): 90-9.
6. Milner KK, Valenstein M. A comparison of guidelines for the treatment of schizophrenia. Psychiatric Services. 2002; 53(7): 888-90.

DRA: Health Services and Systems, Mental Illness
DRE: Communication and Decision Making, Quality of Care
Keywords: Pharmaceuticals, Schizophrenia
MeSH Terms: none